Skip to main content

Therapeutic Monoclonal Antibodies: European Regulatory Issues

  • Chapter
Therapeutic Monoclonal Antibodies

Abstract

Following successful clinical trials by their Transplantation Multicenter Study Group in 1985, Ortho Pharmaceutical was grated a licence by the U.S. FDA the following year for routine administration of their OKT3 murine monoclonal antibody for the prevention of graft rejection in renal transplant patients. It is significant, however, that despite encouraging results from these and other clinical trials employing murine monoclonals produced in vitro or in mouse ascites for the treatment of various cancers (Herlyn and Koprowski, 1982; Miller et al., 1982 and 1983; Foon et al., 1984; Oldham et al., 1984; Sears et al., 1984) no further licences have since been awarded for their use in humans.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

Download references

Authors

Editor information

Carl A. K. Borrebaeck James W. Larrick

Copyright information

© 1990 Stockton Press

About this chapter

Cite this chapter

Brown, J. (1990). Therapeutic Monoclonal Antibodies: European Regulatory Issues. In: Borrebaeck, C.A.K., Larrick, J.W. (eds) Therapeutic Monoclonal Antibodies. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-11894-6_20

Download citation

Publish with us

Policies and ethics